Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activityM Jonathan Fray, Paul V Fish, Gillian A Allan, et al.Journal of Medicinal Chemistry|November 17, 2015
Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial ActivityCharles E Mowbray, Stéphanie Braillard, William Speed, et al.Journal of Medicinal Chemistry|December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and SkinPeter Jones, R Ian Storer, Yogesh A Sabnis, et al.Journal of Medicinal Chemistry|October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral LeishmaniasisCharles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.Journal of Medicinal Chemistry|June 1, 2014
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptorsR Ian Storer, Paul E Brennan, Alan D Brown, et al.Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.Pageof 3